Skip to contentSkip to navigation
From now on, laboratory and sleep care test results will only be available through the MyBiron health portal for people aged 14 and older. Create your account or learn more.

Apha-1-globulin

The apha-1-globulin fraction is mostly composed of alpha-1-glycoprotein and alpha-1-antitrypsin.

Alpha-1-glycoprotein (orosomucoid) is an acute-phase protein and is therefore an indicator of inflammation (rheumatoid arthritis, inflammatory bowel disease, etc.). The level of inflammation is however more conveniently evaluated using the level of CRP (C-Reactive Protein) or the measurement of the sedimentation rate.

Alpha-1-antitrpysin (α-1-AT) is a protein that protects the lungs and liver from damage that could be caused by the activation of cell digesting enzymes, a normal body defence mechanism. Levels of α-1-AT are determined by two copies of a gene, each responsible for the synthesis of half of the available α-1-AT. Levels of α-1-AT below 30% of normal values indicate a risk of damage caused by the activation of the digesting enzymes (early pulmonary emphysema or liver cirrhosis). Low levels can also be observed in situations that lead to a general decline in serum proteins such as kidney disease, malnutrition and certain cancers.

Alpha-1-antitrypsin is an “acute-phase protein”. Levels will increase under acute or chronic inflammatory conditions, infections and certain cancers. These acute-phase increases could temporarily mask an otherwise genetically depressed α-1-AT level.

Term of the Week

Predictive medicine

Medicine that links medical knowledge with data to predict a patient’s potential health problems. Examples include artificial intelligence and genetics.